DRUG-RELEASE FROM AN OPHTHALMIC INSERT OF A BETA-BLOCKER AS AN OCULAR DRUG-DELIVERY SYSTEM

被引:0
|
作者
SASAKI, H
TEI, C
NISHIDA, K
NAKAMURA, J
机构
关键词
DRUG DELIVERY; OCULAR DELIVERY; EYE; GLAUCOMA; BETA-BLOCKER;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Disc type ophthalmic inserts of beta-blockers were prepared with various polymers and drug release from the inserts were investigated. Tilisolol and poly(2-hydroxypropyl methacrylate) (HPM) were mainly used as models of beta-blocker and polymer for an ophthalmic insert. Release of tilisolol from ten different types of polymer inserts showed a variety patterns. In the inserts prepared with HPM and poly(2-hydroxyethyl methacrylate), the release data were fitted to a simple power equation and it was found that the release characteristics of tilisolol from these systems followed behavior conforming to a non-Fickian mechanism. The release of tilisolol from an HPM insert was examined under various conditions. Medium pH and medium temperature influenced the release of tilisolol from the HPM insert. Release of tilisolol from the HPM insert was not affected by drug load but by the amount of HPM. Various beta-blockers also showed controlled release from their HPM inserts. Macromolecular dye and insulin showed a slow release with an initial burst effect. Release data for an HPM insert under various conditions were also fitted to a simple power equation. The in vivo release pattern of tilisolol from an HPM insert in rabbit conjunctival sac reflected the in vitro release pattern. The constant releasing rate of tilisolol in the precorneal area was observed after application of the HPM insert of tilisolol in the puncta plugged rabbit. These results indicate that the polymer inserts can control drug release and might improve ocular bioavailability and reduce toxicity of ophthalmic drugs.
引用
收藏
页码:127 / 137
页数:11
相关论文
共 50 条
  • [21] In Vitro Release Mechanisms of Doxorubicin From a Clinical Bead Drug-Delivery System
    Ahnfelt, Emelie
    Sjogren, Erik
    Hansson, Per
    Lennernas, Hans
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (11) : 3387 - 3398
  • [22] One-side-coated insert as a unique ophthalmic drug delivery system
    Sasaki, H
    Nagano, T
    Sakanaka, K
    Kawakami, S
    Nishida, K
    Nakamura, J
    Ichikawa, N
    Iwashita, J
    Nakamura, T
    Nakashima, M
    JOURNAL OF CONTROLLED RELEASE, 2003, 92 (03) : 241 - 247
  • [23] A Pillararene-Based Ternary Drug-Delivery System with Photocontrolled Anticancer Drug Release
    Yu, Guocan
    Yu, Wei
    Mao, Zhengwei
    Gao, Changyou
    Huang, Feihe
    SMALL, 2015, 11 (08) : 919 - 925
  • [24] RETROMETABOLIC DRUG DESIGN CONCEPTS IN OPHTHALMIC TARGET-SPECIFIC DRUG-DELIVERY
    BODOR, N
    ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (01) : 21 - 38
  • [25] Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System
    Rudeen, Kayla M.
    Liu, Wenqiang
    Mieler, William F.
    Kang-Mieler, Jennifer J.
    CURRENT EYE RESEARCH, 2022, 47 (07) : 1034 - 1042
  • [26] CLONIDINE AND VASODILATING BETA-BLOCKER ANTIHYPERTENSIVE DRUG INTERACTION
    PETTINGER, WA
    MITCHELL, HC
    GULLNER, HG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1977, 22 (02) : 164 - 171
  • [27] MEASUREMENT OF RAPID RELEASE KINETICS FOR DRUG-DELIVERY
    PLIQUETT, U
    PRAUSNITZ, MR
    CHIZMADZHEV, YA
    WEAVER, JC
    PHARMACEUTICAL RESEARCH, 1995, 12 (04) : 549 - 555
  • [28] Beta-Blocker Supplementation of Standard Drug Treatment for Schizophrenia
    Shek, Elena
    Bardhan, Sabyasachi
    Cheine, Maxim V.
    Ahonen, Juha
    Wahlbeck, Kristian
    SCHIZOPHRENIA BULLETIN, 2010, 36 (06) : 1079 - 1080
  • [29] BETA-BLOCKER DRUG-INTERACTIONS .127.
    DIPALMA, JR
    AMERICAN FAMILY PHYSICIAN, 1983, 28 (03) : 249 - 251
  • [30] Hydrogel conjunctival insert for ocular drug delivery.
    Leahy, CD
    Eilis, JY
    Eilis, EE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S766 - S766